Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Falling Comet

Download real time

868.85 24.45 (2.90%)

34.39% Fall from 52W High

1.2M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

0.9

Beta 1Year

Low volatility

US FDA Approval

Zydus Life receives final approval from the US FDA to manufacture Jaythari (Deflazacort) tablets See details

Zydus Lifesciences Ltd. RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Zydus Lifesciences technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis